NLSP NLS PharmaceuticsWatchlist
About NLS Pharmaceutics Company
NLS Pharmaceutics AG engages in the discovery and development of drug therapies to treat rare and complex central nervous systems disorders. These disorders include narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as ADHD. The company was founded by Ronald Hafner and Alexander Zwyer in August 2015 and is headquartered in Stans, Switzerland.
Sector Update: Health Care Stocks Rise in Afternoon Trading
Health care stocks rose Friday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.3%. The iShares Biotechnology ETF (IBB) was up 0.7%. In corpora
Top Midday Gainers
Bit Brother (BETS) said it has purchased 3,300 units of Antminer S19 miners to boost its mining operations. Shares of the company surged 28%, with over 175 million shares traded intraday compared with
Altimmune ALT Phase 2 Data; NLS Pharmaceutics NLSP Options Agreement